Goldman Small Cap Research Issues New Sector Snapshot Featuring PetVivo Holdings, Inc.

BALTIMORE, MD / ACCESSWIRE / July 20, 2020 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Sector Snapshot on the Veterinary Health segment, in which PetVivo Holdings, Inc., (OTCQB:PETV) is prominently featured. PetVivo is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. Other companies discussed in the report include Elanco Animal Health, IDEXX Labs and Zoetis. To view the new research report, or other PetVivo research, along with disclosures and disclaimers, or to download it in its entirety, please visit https://bit.ly/3hiJGXk,

In the Sector Snapshot, analyst Rob Goldman provides a brief overview of the sector, and why PetVivo is the low-priced alternative to the segment's key leaders.

Goldman noted, "The Animal Health Market appears to have the wind at its back. We have identified four players that are must-watch, in our view, including PetVivo, which offers considerable upside relative to its higher-priced, higher valuation peers. The Company is well-positioned to emerge as the standard of care for the treatment of osteoarthritis (OA) in dogs and horses, an unmet need representing an estimated $3.2B market. Following its $15M R&D and product development investment, Kush® is set for a second half 2020 launch, with pre-production runs beginning in a few weeks in the Company's new in-house facility"

"PETV is no one trick pony as the Company's pipeline of products includes 17 therapeutic devices for veterinary and human clinical applications. Adding what could be considered a bonus to its overall valuation, PETV has already begun its secondary objective of engaging in licensing its technology in varying therapeutic categories."

"Clearly, we are not the only PETV followers that are fans of the Company's initiatives. Since our Note on June 19, 2020, the stock has more than doubled on steadily rising volume and recently closed at nearly twice its share price a month ago. Our financial projections and price target are under review but we believe that PETV's shares can support a valuation substantially greater than its 52-week high of $1.00. Judging by the valuations afforded the peer group highlighted in this snapshot, reaching our prior published target of $3.00 appears to be in the cards."

About Goldman Small Cap Research: Founded in 2009by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

This press release contains excerpts of our most recently published Sector Snapshot in which PetVivo Holdings, Inc. is prominently featured. At this time, our price target is under review. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from PetVivo Holdings, Inc. ("the Company") and other featured companies including Elanco Animal Health Inc, IDEXX Laboratories, Inc., and Zoetis, Inc. The information includes authorized press releases or legal disclosures made in their filings with the U.S. Securities and Exchange Commission http://www.sec.gov.

Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets, and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, sector or industry snapshot, podcast interview, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency. A Speculative Buy rating for our covered companies is defined as a company that we believe exhibits the potential to generate outsized returns despite inherent, above-average business, market, or financial risk. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Goldman Small Cap Research was not compensated for the production and distribution of this research note or the associated press release and distribution. From 2016-2019, GSCR's principal was compensated by Marble Arch Research Inc. to produce reports and updates on PETV on behalf of Marble Arch Research Inc. and under its banner. In the future, GSCR may be compensated by the Company or a third party for research report and press release production and distribution. GSCR was not compensated by any other companies mentioned in this report.

Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com

SOURCE: Goldman Small Cap Research